Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Groen

Showing results (521-530 of 565) with videos related to

Pageof 57
Sort By:
Trials|October 22, 2018
Dexamethasone therapy versus surgery for chronic subdural haematoma (DECSA trial): study protocol for a randomised controlled trialIshita P Miah, Dana C Holl, Wilco C Peul, et al.
Therapeutic Advances in Medical Oncology|August 29, 2022
Investigation of the added value of CT-based radiomics in predicting the development of brain metastases in patients with radically treated stage III NSCLCSimon A Keek, Esma Kayan, Avishek Chatterjee, et al.
European Journal of Cancer (Oxford, England : 1990)|June 30, 2019
EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancerC R Lindsay, F H Blackhall, A Carmel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2017
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II TrialDong-Wan Kim, Marcello Tiseo, Myung-Ju Ahn, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 4, 2023
Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small cell lung cancerMirte Muller, Myron G Best, Vincent van der Noort, et al.
JTO Clinical and Research Reports|September 6, 2022
Long-Term Efficacy and Safety of Brigatinib in Crizotinib-Refractory <i>ALK</i>+ NSCLC: Final Results of the Phase 1/2 and Randomized Phase 2 (ALTA) TrialsScott N Gettinger, Rudolf M Huber, Dong-Wan Kim, et al.
American Journal of Respiratory and Critical Care Medicine|December 18, 2014
Novel genes for airway wall thickness identified with combined genome-wide association and expression analysesAkkelies E Dijkstra, Dirkje S Postma, Bram van Ginneken, et al.
The Lancet. Oncology|October 3, 2024
Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trialJürgen Wolf, Maximilian Hochmair, Ji-Youn Han, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 21, 2014
A genome-wide association meta-analysis of preschool internalizing problemsKelly S Benke, Michel G Nivard, Fleur P Velders, et al.
The European Respiratory Journal|November 29, 2014
Towards a close computed tomography monitoring approach for screen detected subsolid pulmonary nodules?Ernst T Scholten, Pim A de Jong, Bartjan de Hoop, et al.
Pageof 57

Showing results (521-530 of 565) with videos related to

Sort By:
Pageof 57
Trials|October 22, 2018
Dexamethasone therapy versus surgery for chronic subdural haematoma (DECSA trial): study protocol for a randomised controlled trialIshita P Miah, Dana C Holl, Wilco C Peul, et al.
Therapeutic Advances in Medical Oncology|August 29, 2022
Investigation of the added value of CT-based radiomics in predicting the development of brain metastases in patients with radically treated stage III NSCLCSimon A Keek, Esma Kayan, Avishek Chatterjee, et al.
European Journal of Cancer (Oxford, England : 1990)|June 30, 2019
EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancerC R Lindsay, F H Blackhall, A Carmel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2017
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II TrialDong-Wan Kim, Marcello Tiseo, Myung-Ju Ahn, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 4, 2023
Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small cell lung cancerMirte Muller, Myron G Best, Vincent van der Noort, et al.
JTO Clinical and Research Reports|September 6, 2022
Long-Term Efficacy and Safety of Brigatinib in Crizotinib-Refractory <i>ALK</i>+ NSCLC: Final Results of the Phase 1/2 and Randomized Phase 2 (ALTA) TrialsScott N Gettinger, Rudolf M Huber, Dong-Wan Kim, et al.
American Journal of Respiratory and Critical Care Medicine|December 18, 2014
Novel genes for airway wall thickness identified with combined genome-wide association and expression analysesAkkelies E Dijkstra, Dirkje S Postma, Bram van Ginneken, et al.
The Lancet. Oncology|October 3, 2024
Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trialJürgen Wolf, Maximilian Hochmair, Ji-Youn Han, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 21, 2014
A genome-wide association meta-analysis of preschool internalizing problemsKelly S Benke, Michel G Nivard, Fleur P Velders, et al.
The European Respiratory Journal|November 29, 2014
Towards a close computed tomography monitoring approach for screen detected subsolid pulmonary nodules?Ernst T Scholten, Pim A de Jong, Bartjan de Hoop, et al.
Pageof 57